STRATEC SE

Declaration of Voting Results & Voting Rights Announcements • Dec 18, 2009

News Details

Voting Rights Announcements | 18 December 2009 20:20

STRATEC Biomedical Systems AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

STRATEC Biomedical Systems AG / Release of an announcement according to Article 21, Section 1 of the WpHG [the German Securities Trading Act] (share)

18.12.2009

Dissemination of a Voting Rights announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---

1st voting rights anouncement

Threadneedle Investment Funds ICVC, London, UK, has notified us pursuant to
§ 21 sec. 1 WpHG on 15 December 2009, that on 11 December 2009 the share of
voting rights in STRATEC Biomedical Systems AG, Birkenfeld, Germany, ISIN:
DE0007289001, went below the threshold of 5% and that the percentage of
voting rights on that day amounted to 4.848% (554,837 shares). These voting
rights are directly held by Threadneedle Investment Funds ICVC.

Threadneedle Investment Services Limited, London, UK, has notified us
pursuant to § 21 sec. 1 WpHG on 15 December 2009, that on 11 December 2009
the share of voting rights in STRATEC Biomedical Systems AG, Birkenfeld,
Germany, ISIN: DE0007289001, went below the threshold of 5% and that the
percentage of voting rights on that day amounted to 4.848% (554,837
shares). Pursuant to § 22 para. 1 sent. 1 No. 6 WpHG, these voting rights
are in their entirety attributable to Threadneedle Investment Services
Limited, London, UK. These voting rights are directly held by Threadneedle
Investment Funds ICVC.

2nd voting rights anouncement

Threadneedle Asset Management Limited, London, UK, has notified us pursuant
to § 21 sec. 1 WpHG on 17 December 2009, that on 15 December 2009 the share
of voting rights in STRATEC Biomedical Systems AG, Birkenfeld, Germany,
ISIN: DE0007289001, went below the threshold of 5% and that the percentage
of voting rights on that day amounted to 4.961% (567,788 shares). These
voting rights are in their entirety attributable to Asset Management
Limited, London, UK. pursuant to § 22 para. 1 sent. 1 No. 6 WpHG. These
voting rights are held directly by Threadneedle Investment Funds ICVC and
other Funds.

18.12.2009 Ad hoc announcement, Financial News and Media Release distributed by DGAP.
Media archive at www.dgap-medientreff.de and www.dgap.de

---

Language: English
Company: STRATEC Biomedical Systems AG
Gewerbestraße 37
75217 Birkenfeld
Deutschland
Internet: www.stratec-biomedical.de

End of News DGAP News-Service

---